Endogenous and Synthetic Cannabinoids as Therapeutics in Retinal Disease
The functional significance of cannabinoids in ocular physiology and disease has been reported some decades ago. In the early 1970s, subjects who smoked Cannabis sativa developed lower intraocular pressure (IOP). This led to the isolation of phytocannabinoids from this plant and the study of their t...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2016-01-01
|
| Series: | Neural Plasticity |
| Online Access: | http://dx.doi.org/10.1155/2016/8373020 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850229637650579456 |
|---|---|
| author | Despina Kokona Panagiota-Christina Georgiou Mihalis Kounenidakis Foteini Kiagiadaki Kyriaki Thermos |
| author_facet | Despina Kokona Panagiota-Christina Georgiou Mihalis Kounenidakis Foteini Kiagiadaki Kyriaki Thermos |
| author_sort | Despina Kokona |
| collection | DOAJ |
| description | The functional significance of cannabinoids in ocular physiology and disease has been reported some decades ago. In the early 1970s, subjects who smoked Cannabis sativa developed lower intraocular pressure (IOP). This led to the isolation of phytocannabinoids from this plant and the study of their therapeutic effects in glaucoma. The main treatment of this disease to date involves the administration of drugs mediating either the decrease of aqueous humour synthesis or the increase of its outflow and thus reduces IOP. However, the reduction of IOP is not sufficient to prevent visual field loss. Retinal diseases, such as glaucoma and diabetic retinopathy, have been defined as neurodegenerative diseases and characterized by ischemia-induced excitotoxicity and loss of retinal neurons. Therefore, new therapeutic strategies must be applied in order to target retinal cell death, reduction of visual acuity, and blindness. The aim of the present review is to address the neuroprotective and therapeutic potential of cannabinoids in retinal disease. |
| format | Article |
| id | doaj-art-2a9e5ac9a013419f9c8baef3bae0677f |
| institution | OA Journals |
| issn | 2090-5904 1687-5443 |
| language | English |
| publishDate | 2016-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Neural Plasticity |
| spelling | doaj-art-2a9e5ac9a013419f9c8baef3bae0677f2025-08-20T02:04:09ZengWileyNeural Plasticity2090-59041687-54432016-01-01201610.1155/2016/83730208373020Endogenous and Synthetic Cannabinoids as Therapeutics in Retinal DiseaseDespina Kokona0Panagiota-Christina Georgiou1Mihalis Kounenidakis2Foteini Kiagiadaki3Kyriaki Thermos4University of Crete, School of Medicine, Department of Pharmacology, Heraklion, 71003 Crete, GreeceUniversity of Crete, School of Medicine, Department of Pharmacology, Heraklion, 71003 Crete, GreeceUniversity of Crete, School of Medicine, Department of Pharmacology, Heraklion, 71003 Crete, GreeceUniversity of Crete, School of Medicine, Department of Pharmacology, Heraklion, 71003 Crete, GreeceUniversity of Crete, School of Medicine, Department of Pharmacology, Heraklion, 71003 Crete, GreeceThe functional significance of cannabinoids in ocular physiology and disease has been reported some decades ago. In the early 1970s, subjects who smoked Cannabis sativa developed lower intraocular pressure (IOP). This led to the isolation of phytocannabinoids from this plant and the study of their therapeutic effects in glaucoma. The main treatment of this disease to date involves the administration of drugs mediating either the decrease of aqueous humour synthesis or the increase of its outflow and thus reduces IOP. However, the reduction of IOP is not sufficient to prevent visual field loss. Retinal diseases, such as glaucoma and diabetic retinopathy, have been defined as neurodegenerative diseases and characterized by ischemia-induced excitotoxicity and loss of retinal neurons. Therefore, new therapeutic strategies must be applied in order to target retinal cell death, reduction of visual acuity, and blindness. The aim of the present review is to address the neuroprotective and therapeutic potential of cannabinoids in retinal disease.http://dx.doi.org/10.1155/2016/8373020 |
| spellingShingle | Despina Kokona Panagiota-Christina Georgiou Mihalis Kounenidakis Foteini Kiagiadaki Kyriaki Thermos Endogenous and Synthetic Cannabinoids as Therapeutics in Retinal Disease Neural Plasticity |
| title | Endogenous and Synthetic Cannabinoids as Therapeutics in Retinal Disease |
| title_full | Endogenous and Synthetic Cannabinoids as Therapeutics in Retinal Disease |
| title_fullStr | Endogenous and Synthetic Cannabinoids as Therapeutics in Retinal Disease |
| title_full_unstemmed | Endogenous and Synthetic Cannabinoids as Therapeutics in Retinal Disease |
| title_short | Endogenous and Synthetic Cannabinoids as Therapeutics in Retinal Disease |
| title_sort | endogenous and synthetic cannabinoids as therapeutics in retinal disease |
| url | http://dx.doi.org/10.1155/2016/8373020 |
| work_keys_str_mv | AT despinakokona endogenousandsyntheticcannabinoidsastherapeuticsinretinaldisease AT panagiotachristinageorgiou endogenousandsyntheticcannabinoidsastherapeuticsinretinaldisease AT mihaliskounenidakis endogenousandsyntheticcannabinoidsastherapeuticsinretinaldisease AT foteinikiagiadaki endogenousandsyntheticcannabinoidsastherapeuticsinretinaldisease AT kyriakithermos endogenousandsyntheticcannabinoidsastherapeuticsinretinaldisease |